Cytosorbents Corp.
CTSO Real Time Price USDRecent trades of CTSO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CTSO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$10,000 Jul 18, 2012 Issue: Defense
Estimated quarterly lobbying spending
CTSO Revenue by Segment or Geography
New patents grants
-
Patent Title: Multi-functional hemocompatible porous bead sorbent for removing protein based toxins and potassium from biological fluids Jan. 28, 2025
-
Patent Title: Crosslinked polysaccharide based absorbents for removal of anti-a and/or anti-b antibodies from human plasma and whole blood Oct. 22, 2024
-
Patent Title: Method of treating traumatic brain injury Sep. 03, 2024
-
Patent Title: Connector assembly and methods of use Apr. 30, 2024
-
Patent Title: Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules Nov. 28, 2023
-
Patent Title: Hemocompatibility modifiers for cross-linked polymeric material Sep. 12, 2023
-
Patent Title: Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids Aug. 15, 2023
-
Patent Title: Methods for reducing contamination in a biological substance Mar. 14, 2023
-
Patent Title: Methods for removal of toxins from blood using an extracorporeal circuit comprised of a hollow-fiber filter module and polymer sorbent in combination Dec. 21, 2021
-
Patent Title: Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules Jul. 20, 2021
-
Patent Title: Method of treating inflammation Jul. 13, 2021
-
Patent Title: Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids Jun. 22, 2021
-
Patent Title: Hemocompatibility modifiers for cross-linked polymeric material Jun. 01, 2021
-
Patent Title: Method of treating inflammation Apr. 06, 2021
-
Patent Title: Method of treating inflammation Mar. 16, 2021
-
Patent Title: Process for functionalizing a biocompatible polymeric bead, the functionalized beads, and the beads produced thereby Jan. 12, 2021
-
Patent Title: Polymeric sorbent for removal of impurities from whole blood and blood products Oct. 01, 2019
-
Patent Title: Use of gastrointestinally administered porous enteron sorbent polymers to prevent or treat radiation induced mucositis, esophagitis, enteritis, colitis, and gastrointestinal acute radiation syndrome Jun. 11, 2019
-
Patent Title: Polymeric sorbent for removal of impurities from whole blood and blood products Sep. 04, 2018
-
Patent Title: Method of treating inflammation Jul. 31, 2018
-
Patent Title: Compositions and methods useful in selectively modifying the internal and external surfaces of porous polymer beads Apr. 03, 2018
-
Patent Title: Use of gastrointestinally administered porous enteron sorbent polymers to prevent or treat radiation induced mucositis, esophagitis, enteritis, colitis, and gastrointestinal acute radiation syndrome Apr. 03, 2018
-
Patent Title: Method of treating inflammation Aug. 01, 2017
-
Patent Title: Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood Jan. 08, 2013
-
Patent Title: Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products Dec. 18, 2012
-
Patent Title: Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood Dec. 11, 2012
-
Patent Title: Size-selective polymer system Jul. 03, 2012
-
Patent Title: Size-selective hemoperfusion polymeric adsorbents Jan. 25, 2011
-
Patent Title: Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood Dec. 07, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to CTSO
Recent picks made for CTSO stock on CNBC
ETFs with the largest estimated holdings in CTSO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $CTSO stock a Buy, Sell, or Hold?
- What is the price target for $CTSO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $CTSO stock?
- Who owns the most shares of $CTSO stock?
- What funds own $CTSO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CTSO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.